{
    "clinical_study": {
        "@rank": "19887", 
        "arm_group": {
            "arm_group_label": "Stress Urinary Incontinence", 
            "description": "Stress Urinary Incontinence"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, observational, multicenter study of women with surgically-correctable\n      stress urinary incontinence who undergo a TOT-sling operative procedure."
        }, 
        "brief_title": "Urethral Length and TOT (Transobturator Tape) Positioning", 
        "completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "condition": "Stress Urinary Incontinence", 
        "condition_browse": {
            "mesh_term": [
                "Urinary Incontinence", 
                "Urinary Incontinence, Stress"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, observational, multicenter study of women with surgically-correctable\n      stress urinary incontinence who undergo a TOT-sling operative procedure. Data will be\n      collected from preoperative urogynecological testing and medical histories. Outcome data\n      will be collected 1-3 days and 6 months after procedure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patient has objective demonstrable signs of stress urinary incontinence (SUI),\n             including patients with intrinsic sphincter deficiency (ISD). Objective testing\n             includes: standing stress test, urodynamics evaluation, or pad test.\n\n          2. Patient is age 18 or older.\n\n          3. Patient agrees to participate in the study, including completion of all study-related\n             procedures and evaluations, and documents this agreement by signing the Institutional\n             Review Board (IRB)/Ethic commission (EC)-approved informed consent.\n\n          4. Patient is able to fill in all questionnaires (on judgement of investigator)\n\n        Exclusion Criteria:\n\n          1. Patient has an associated or suspected neurological disease.\n\n          2. Patient has an active lesion or present injury to perineum or urethra.\n\n          3. Patient has a urethral obstruction.\n\n          4. Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical\n             treatment.\n\n          5. Patient currently has an urinary tract infection."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population includes women with surgically-corrected stress urinary incontinence\n        who undergo a TOT operative procedure."
            }
        }, 
        "enrollment": {
            "#text": "123", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753011", 
            "org_study_id": "TOT 1/2-Rule"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Stress urinary Incontinence", 
            "Transobturator sling", 
            "TOT"
        ], 
        "lastchanged_date": "December 17, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hagen", 
                        "country": "Germany"
                    }, 
                    "name": "Department of Gynecology and Obstetrics, Lutheran Hospital Hagen-Haspe"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frauenfeld", 
                        "country": "Switzerland", 
                        "state": "Thurgau"
                    }, 
                    "name": "Blasenzentrum, Cantonal Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Switzerland"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective, Observational Study: Can Pelvic Floor Ultrasound Help to Optimize TOT (Transobturator Tape) Positioning?", 
        "overall_official": {
            "affiliation": "Cantonal Hospital, Frauenfeld", 
            "last_name": "Volker Viereck, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome of the TOT procedure will be assessed using a combination of objective and subjective criteria. Patients with a negative stress test, a negative 1-h pad test (less than 2 g) and the degree of subjective suffering improving to over 90% (VAS score of 0-1) at 6 months follow-up evaluation are classified as cured. All other patients are classified as treatment failure even if one aspect shows marked improvement from the preoperative condition.", 
            "measure": "Cure rate", 
            "safety_issue": "No", 
            "time_frame": "6 months postoperative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753011"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cantonal Hospital, Frauenfeld", 
            "investigator_full_name": "Prof. Dr. Volker Viereck", 
            "investigator_title": "Prof. Dr. Volker Viereck", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Urethral length will be measured by pelvic floor sonography.", 
                "measure": "Urethral length", 
                "safety_issue": "No", 
                "time_frame": "Preoperative"
            }, 
            {
                "description": "Linear urethral dorsocaudal movement (LUDM) will be assessed by pelvic floor sonography.", 
                "measure": "Linear urethral dorsocaudal movement (LUDM)", 
                "safety_issue": "No", 
                "time_frame": "Preoperative"
            }, 
            {
                "description": "The position of the TOT along the urethra will be determined by pelvic floor sonography and expressed as percentage of urethral length.", 
                "measure": "Urethral tape position", 
                "safety_issue": "No", 
                "time_frame": "1-3 days and 6 months postoperative"
            }, 
            {
                "description": "To characterize the location of the TOT, the shortest distance between the tape and the longitudinal smooth muscle (LSM) complex of the urethra will be measured by pelvic floor sonography.", 
                "measure": "Distance between tape and longitudinal smooth muscle (LSM) complex", 
                "safety_issue": "No", 
                "time_frame": "1-3 days and 6 months postoperative"
            }, 
            {
                "description": "Urodynamic testing will be performed only for patients undergoing recurrent incontinence surgery.", 
                "measure": "Urodynamic testing", 
                "safety_issue": "No", 
                "time_frame": "Preoperative"
            }
        ], 
        "source": "Cantonal Hospital, Frauenfeld", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cantonal Hospital, Frauenfeld", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2007", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}